Cell and Hydrogel-Integrated Therapies for Intervertebral Disc Regeneration

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedics

Background:

• Intervertebral disc degeneration (IDD) is a primary cause of low back pain (LBP), leading to significant disability and healthcare expenses.
• Current treatments for IDD often manage symptoms rather than address root causes like nucleus pulposus (NP) cell decline and reduced extracellular matrix (ECM) synthesis.
• Cell therapy presents a potential solution by replacing or activating cells to enhance ECM production, but transplanted cells face challenges in the harsh IDD microenvironment.

Purpose of the Study:

• To review the fundamental concepts of IDD progression and current treatment strategies.
• To explore the potential of stem/progenitor cell therapy for IDD.
• To highlight the role of hydrogels as delivery systems in enhancing cell therapy for IDD.

Main Methods:

• Review of existing literature on IDD, cell therapy, and hydrogel applications.
• Analysis of hydrogel properties relevant to supporting cell therapy in IDD.
• Discussion of various hydrogel-based cell therapy methods and recent advancements.

Main Results:

• Hydrogels mimic the ECM, providing a supportive niche for transplanted cells in IDD.
• Hydrogels facilitate controlled delivery of therapeutics and biologics, improving cell survival and function.
• Various hydrogel formulations are being explored for effective IDD treatment strategies.

Conclusions:

• Hydrogel-assisted cell therapy shows significant regenerative potential for IDD.
• Addressing limitations and challenges in current hydrogel-based approaches is crucial for future clinical translation.
• Further research into hydrogel-biomaterial interactions and in vivo efficacy is warranted for advancing IDD treatment.